Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk R Schultz

Showing results (41-50 of 217) with videos related to

Pageof 22
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2005
Cardiac manifestations of graft-versus-host diseaseCynthia Rackley, Kirk R Schultz, Frederick D Goldman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 20, 2011
Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigensHisaki Fujii, Sabine M Ivison, Hiromi Shimizu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 7, 2009
The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held on July 11 and 12, 2008, Holiday Valley, New YorkPatricia K Duffner, Verne S Caviness, Richard W Erbe, et al.
British Journal of Haematology|February 14, 2002
ETV6 (TEL)-AML1 pre-B acute lymphoblastic leukaemia cells are associated with a distinct antigen-presenting phenotypeAngela J Alessandri, Gregor S D Reid, Sharon A Bader, et al.
Clinical Immunology (Orlando, Fla.)|February 17, 2009
Optimizing outcomes of hematopoietic stem cell transplantation for severe combined immunodeficiencyGeoff D E Cuvelier, Kirk R Schultz, Jeff Davis, et al.
Leukemia Research|August 19, 2003
Altered patterns of T cell cytokine production induced by relapsed pre-B ALL cellsGregor S D Reid, Luke Terrett, Angela J Alessandri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 23, 2019
Anti-Thymocyte Globulin Prophylaxis Induces a Decrease in Naive Th Cells to Inhibit the Onset of Chronic Graft-versus-Host Disease: Results from the Canadian Bone Marrow Transplant Group (CBMTG) 0801 StudyLeonie Naeije, Amina Kariminia, Sayeh Abdossamadi, et al.
Blood|May 6, 2018
Plerixafor effectively mobilizes CD56<sup>bright</sup> NK cells in blood, providing an allograft predicted to protect against GVHDPeggy P C Wong, Amina Kariminia, David Jones, et al.
Cytotherapy|August 11, 2024
Expansion and characterization of immune suppressive CD56(bright)Perforin(-) regulatory-like natural killer cells in chronic graft-versus-host diseaseMadeline P Lauener, Erin Tanaka, Ao Mei, et al.
Frontiers in Pediatrics|April 11, 2022
Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?Jacob Rozmus, Sima T Bhatt, Nataliya Prokopenko Buxbaum, et al.
Pageof 22

Showing results (41-50 of 217) with videos related to

Sort By:
Pageof 22
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2005
Cardiac manifestations of graft-versus-host diseaseCynthia Rackley, Kirk R Schultz, Frederick D Goldman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 20, 2011
Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigensHisaki Fujii, Sabine M Ivison, Hiromi Shimizu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 7, 2009
The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held on July 11 and 12, 2008, Holiday Valley, New YorkPatricia K Duffner, Verne S Caviness, Richard W Erbe, et al.
British Journal of Haematology|February 14, 2002
ETV6 (TEL)-AML1 pre-B acute lymphoblastic leukaemia cells are associated with a distinct antigen-presenting phenotypeAngela J Alessandri, Gregor S D Reid, Sharon A Bader, et al.
Clinical Immunology (Orlando, Fla.)|February 17, 2009
Optimizing outcomes of hematopoietic stem cell transplantation for severe combined immunodeficiencyGeoff D E Cuvelier, Kirk R Schultz, Jeff Davis, et al.
Leukemia Research|August 19, 2003
Altered patterns of T cell cytokine production induced by relapsed pre-B ALL cellsGregor S D Reid, Luke Terrett, Angela J Alessandri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 23, 2019
Anti-Thymocyte Globulin Prophylaxis Induces a Decrease in Naive Th Cells to Inhibit the Onset of Chronic Graft-versus-Host Disease: Results from the Canadian Bone Marrow Transplant Group (CBMTG) 0801 StudyLeonie Naeije, Amina Kariminia, Sayeh Abdossamadi, et al.
Blood|May 6, 2018
Plerixafor effectively mobilizes CD56<sup>bright</sup> NK cells in blood, providing an allograft predicted to protect against GVHDPeggy P C Wong, Amina Kariminia, David Jones, et al.
Cytotherapy|August 11, 2024
Expansion and characterization of immune suppressive CD56(bright)Perforin(-) regulatory-like natural killer cells in chronic graft-versus-host diseaseMadeline P Lauener, Erin Tanaka, Ao Mei, et al.
Frontiers in Pediatrics|April 11, 2022
Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?Jacob Rozmus, Sima T Bhatt, Nataliya Prokopenko Buxbaum, et al.
Pageof 22